1. Homepage
  2. Equities
  3. Taiwan
  4. Taiwan Stock Exchange
  5. Bionime Corporation
  6. Summary
    4737   TW0004737002

BIONIME CORPORATION

(4737)
  Report
End-of-day quote Taiwan Stock Exchange  -  05-19
71.80 TWD   +0.42%
05/11Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/14Bionime containerized applications have proven to quickly go to the cloud and leverage AWS to solve deployment issues
AQ
03/29Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Taiwan Stock Exchange
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
71.8 71.9 72 71.5 71.8 Last
24024 35005 29204 32039 12337 Volume
+0.14% +0.14% +0.14% -0.69% +0.42% Change
Estimated financial data (e)
More Financials
Company
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the... 
More about the company
All news about BIONIME CORPORATION
05/11Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/14Bionime containerized applications have proven to quickly go to the cloud and leverage ..
AQ
03/29Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/22BIONIME : The Board of Directors resolution of the capital reduction for treasury stocks a..
PU
03/22BIONIME : The Company's independent directors raised opinions to board resolutions.
PU
03/22Bionime Corporation Announces Cash Dividend for 2021
CI
01/28Bionime Corporation Announces Replacement of the Representative of the Its Institutiona..
CI
01/10Bionime Corporation Announce Demise of Lin,Ming-Hsiang, Institutional Director
CI
2021Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ende..
CI
2021Bionime Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
2021Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
2021Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2021Bionime Corporation Announces Dividend for the Year 2020
CI
2021Bionime Corporation Announces Change to the Principal Accounting Officer of the Company
CI
2020Bionime Corporation Reports Earnings Results for the Third Quarter Ended September 30, ..
CI
More news
News in other languages on BIONIME CORPORATION
05/11Bionime Corporation annonce ses résultats pour le premier trimestre terminé le 31 mars ..
03/29Bionime Corporation annonce ses résultats pour l'année complète se terminant le 31 déce..
03/22Bionime Corporation annonce un dividende en espèces pour 2021
01/28Bionime Corporation annonce le remplacement du représentant de son directeur institutio..
01/10Bionime Corporation annonce le décès de Lin,Ming-Hsiang, directeur institutionnel
More news
Chart BIONIME CORPORATION
Duration : Period :
Bionime Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONIME CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Chun Mu Huang Chairman & General Manager
Hui Chen Chen CFO & Senior Manager-Accounting
Pi Hsuan Chen Assistant Manager-Research & Development
Yu Jen Hsu Assistant Manager-Operations
Tai Hsiung Chiang Director & Deputy General Manager-Administration